Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis

Chest

Volumn 116, Issue 6, 1999, Pages 1665-1668

  Salez, Fabienne ^b   Brichet, Anne ^b   Desurmont, Sophie ^b   Grosbois, Jean Marie ^b   Wallaert, Benoit ^b   Tonnel, André Bernard ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Aspergillus; Asthma; Itraconazole; Steroids

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN E; ITRACONAZOLE;

ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ASTHMA; BRONCHOPULMONARY ASPERGILLOMA; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; EOSINOPHILIA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL;

EID: 0010002123     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.6.1665     Document Type: Article

References (23)

1. 1 Basich JE, Graves TS, Baz MN, et al. Allergic bronchopulmonary aspergillosis in cortico-dependent asthmatics. J Allergy Clin Immunol 1981; 68:98-102
2. 2 Clayton DE, Busse WW. Development of allergic bronchopulmonary aspergillosis during treatment of severe asthma with systemic corticosteroids. J Allergy Clin Inmmnol 1981; 67:243-246
3. 3 Nichols D, Dopico GA, Braun S, et al. Acute and chronic pulmonary function changes in allergic bronchopulmonary aspergillosis. Am J Med 1979; 67:631-637
4. 4 Backman KS, Greenberger PA, Patterson R. Airways obstruction in patients with long-term asthma consistent with "irreversible asthma." Chest 1997; 112:1234-1240
5. 5 Greenberger PA. Diagnosis and management of allergic bronchopulmonary aspergillosis. Allergy Proc 1994; 15:335-339
6. 6 Rosenberg M, Patterson R, Roberts M, et al. The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis. Am J Med 1978; 64:599-606
7. 7 Fournier EC. Trial of ketoconazole in allergic bronchopulmonary aspergillosis [letter]. Thorax 1987; 42:831
8. 8 Ellis ME, Halim MA, Spence D, et al. Systemic amphoterin B versus fluconazole in the management of antibiotic resistant neutropenic fever: preliminary observations from a pilot, exploratory study. J Infect 1995; 30:141-146
9. 9 Jennings TS, Hardin TC. Treatment of aspergillosis with itraconazole. Ann Pharmacother 1993; 27:1206-1211
10. 10 Greenberger PA, Miller TP, Roberts M, et al. Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis. Ann Allergy 1993; 70:333-338
11. 11 National Heart, Lung, and Blood Institute. Asthma management and prevention: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, April 1997; Publication No. 98-4051
12. 12 Thompson BH, Stanford W, Galvin JR, et al. Varied radiologic appearances of pulmonary aspergillosis. Radiographics 1995; 15:1273-1284
13. 13 Cleveland KO, Campbell JW. Hallucinations associated with itraconazole [letter]. Clin Infect Dis 1995; 21:456
14. 14 Stark JE. Allergic pulmonary aspergillosis successfully treated with inhalations of nystatin: report of a case. Dis Chest 1967; 51:96-99
15. 15 Shale DJ, Faux JA, Lane DJ. Trial of ketoconazole in non-invasive pulmonary aspergillosis. Thorax 1987; 42:26-31
16. 16 Pannelier C, Vienet A, Chwetzoff E. Itraconazole in systemic aspergillosis: experience in 22 cases [abstract]. Chemotherapy 1992; 38(suppl 1):54
17. 17 Kane GC, Salazar A, Israel HL. Aspergillosis: expanding spectrum of pulmonary disease. Clin Pulm Med 1998; 5:151-157
18. 18 Denning DW, Van Wye JF, Lewiston NJ, et al. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 1991; 100:813-819
19. 19 Nepomuceno BIB, Esrig S, Moos RB. Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole. Chest 1999; 115:364-370
20. 20 Germand P, Tuchais E, Canfrere I, et al. Therapy of allergic bronchopulmonary aspergillosis with itraconazole [abstract]. Am Rev Respir Dis 1992; 145:A736
21. 21 Spencer DA. John P, Ferryman SR, et al. Successful treatment of invasive pulmonary aspergillosis in chronic granulomatous disease with orally administered itraconazole suspension. Am J Respir Crit Care Med 1994; 149:239-241
22. 22 Pacheco A, Martin JA, Cuevas M. Serologic response to itraconazole in allergic bronchopulmonary aspergillosis. Chest 1993; 103:980-981
23. 23 Linthoudt H, Van Raemdonck D, Lerut T, et al. The association of itraconazole and methylprednisolone may give rise to important steroid-related side effects [abstract]. J Heart Lung Transplant 1996; 15:1165